Effect of lipoprotein(a) levels on coronary lesion complexity in patients with acute myocardial infarction: data from the French RICO survey-Reference-Cited by-同舟云学术

Effect of lipoprotein(a) levels on coronary lesion complexity in patients with acute myocardial infarction: data from the French RICO survey

Published:2023-05-18 Issue:17 Volume:30 Page:e81-e83
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:

Author:

Kouame Isabelle M¹²,Farnier Michel¹^ORCID,Chague Frédéric¹²,Maza Maud²,Bichat Florence²,Zeller Marianne¹²^ORCID,Cottin Yves²^ORCID

Affiliation:

1. Physiolopathologie et Epidémiologie Cérébro-Cardiovasculaire (PEC2) EA 7460, UFR sciences de santé, Université de Bourgogne Franche Comté , 7 Bd Jeanne d’Arc , 21000 Dijon, France

2. Cardiology Department, Dijon-Bourgogne University Hospital , 14 Rue Gaffarel, 21000 Dijon , France

Funder

University Hospital of Dijon Bourgogne

Association de Cardiologie de Bourgogne

Fédération Française de Cardiologie

Agence Régionale de Santé de Bourgogne Franche-Comté

Conseil Régional de Bourgogne

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

https://academic.oup.com/eurjpc/advance-article-pdf/doi/10.1093/eurjpc/zwad164/50451843/zwad164.pdf

Reference10 articles.

1. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement;Kronenberg;Eur Heart J,2022

2. High lipoprotein(a) levels predict severity of coronary artery disease in patients hospitalized for an acute myocardial infarction. Data from the French RICO survey;Farnier;J Clin Lipidol,2022

3. Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trial;Stone;Eur Heart J,2018

4. Lesion complexity and outcomes of extended dual antiplatelet therapy after percutaneous coronary intervention;Yeh;J Am Coll Cardiol,2017

5. Statins and lipoprotein(a); facing the residual risk;Tsaban;Eur J Prev Cardiol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management of dyslipidemia in coronary artery disease: the present and the future;Coronary Artery Disease;2024-04-29

2. Lipoprotein(a) and Long-Term Recurrent Infarction After an Acute Myocardial Infarction;The American Journal of Cardiology;2024-01